Members of Canada’s cannabis industry have formed the Cannabis Canada Council, a single national industry association for the sector. The council includes members of the Cannabis Canada Association, the Canadian Medical Cannabis Council, and operators such as Canopy Growth, Tilray, Aurora Cannabis, MedReleaf, Aphria, Emblem, Cronos Group, Hydroapothecary, Emerald Health Therapeutics, The Supreme Cannabis Company, and 48 North Cannabis Co.
The group was formed “to ensure that the needs of both Canada’s medical cannabis patients and the emerging adult consumer use market are addressed.”
The organization has named several industry leaders to serve on its board, including: Dr. Avtar Dhillon from Emerald Health as board chair; Philippe Lucas of Tilray as vice chair, medical use; Jon Fowler, of Supreme as vice chair, adult use; and Allen Rewak, a cannabis industry communications specialist as executive director.
“I am honoured to have been elected as Chair of the Cannabis Canada Council by my peers. We as a board will lead a united sector forward during a historically significant time, as one mutually supportive team. Together we will realize our shared goals of ensuring fair access for patients, successful and comprehensive legalization of adult use, building a robust legal and regulated industry, and keeping cannabis away from underage youth.” – Dhillon in a press release
The organization’s launch comes just months from when Canada is expected to implement a broad adult-use legalization regime.